or
forgot password

Increasing Participation in Cancer Clinical Trials


N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer

Thank you

Trial Information

Increasing Participation in Cancer Clinical Trials


Inclusion Criteria:



- Patients who are potentially eligible for one of the designated clinical trials on
the basis of automated data from pathology reports and other databases

Exclusion Criteria:

- Patients who meet specific exclusion criteria for designated clinical trials

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

Proportion of patients eligible for designated clinical trials who actually enroll in one of these trials

Outcome Time Frame:

Up to three months after the index oncology visit

Safety Issue:

No

Principal Investigator

Carol P. Somkin, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Kaiser Permanente

Authority:

United States: Institutional Review Board

Study ID:

CN-04CSomk-02-B

NCT ID:

NCT00983866

Start Date:

September 2009

Completion Date:

July 2013

Related Keywords:

  • Cancer

Name

Location
Kaiser Permanente Northern California Oakland, California  94612